Prolonged Time to Postop Radiation Linked to Worse Survival in Oral Cavity Cancer
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
WEDNESDAY, July 12, 2023 -- For patients with oral cavity cancer, prolonged surgery to initiation of postoperative radiation therapy (S-PORT) is associated with worse overall survival, according to a study published online July 9 in JAMA Otolaryngology-Head & Neck Surgery to coincide with the American Head and Neck Society 11th International Conference on Head and Neck Cancer, held from July 8 to 12 in Montreal.
Gabriel S. Dayan, M.D., from the Centre Hospitalier de l'Université de Montréal, and colleagues conducted a multicenter cohort study at eight academic centers to report treatment delays for patients with oral cavity cancer who underwent surgery and adjuvant radiation therapy. Data were included for 1,368 patients.
The researchers found that the median S-PORT interval was 56 days, and 80 percent of patients waited more than 42 days. The median radiation therapy interval (RTI) was 43 days, with 26 percent of patients having an interval of more than 46 days. Between institutions, there were variations in treatment time for the S-PORT interval and RTI. In the cohort, three-year overall survival was 68 percent. Patients with a prolonged S-PORT interval had worse survival at three years in a univariate analysis (66 versus 77 percent; odds ratio, 1.75), whereas no association was seen for a prolonged RTI with overall survival. A prolonged S-PORT interval remained independently associated with overall survival in the multivariable model (hazard ratio, 1.39).
"Unlike patient and tumor-intrinsic factors associated with mortality in head and neck cancer, treatment delays represent a modifiable risk factor and should be prioritized by the multidisciplinary teams," the authors write.
Several authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted July 2023
Read this next
Vaginal Cancer Incidence Increasing Globally
WEDNESDAY, July 3, 2024 -- The incidence of vaginal cancer is increasing globally, according to a study published online June 25 in BJOG: An International Journal of Obstetrics...
Nudging Both Clinicians, Patients May Increase Serious Illness Conversations
TUESDAY, July 2, 2024 -- Combining clinician- and patient-directed nudges may help to promote serious illness conversations (SICs) in cancer care, according to a study published...
Perioperative Chemo Improves Progression-Free Survival in Pancreatic Cancer
TUESDAY, July 2, 2024 -- For patients with resectable pancreatic ductal adenocarcinoma (PDAC), the 12-month progression-free survival (PFS) may be increased with neoadjuvant...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.